Correlation Between Alcoa Corp and Spero Therapeutics
Can any of the company-specific risk be diversified away by investing in both Alcoa Corp and Spero Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Alcoa Corp and Spero Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Alcoa Corp and Spero Therapeutics, you can compare the effects of market volatilities on Alcoa Corp and Spero Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Alcoa Corp with a short position of Spero Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Alcoa Corp and Spero Therapeutics.
Diversification Opportunities for Alcoa Corp and Spero Therapeutics
-0.68 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Alcoa and Spero is -0.68. Overlapping area represents the amount of risk that can be diversified away by holding Alcoa Corp and Spero Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Spero Therapeutics and Alcoa Corp is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Alcoa Corp are associated (or correlated) with Spero Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Spero Therapeutics has no effect on the direction of Alcoa Corp i.e., Alcoa Corp and Spero Therapeutics go up and down completely randomly.
Pair Corralation between Alcoa Corp and Spero Therapeutics
Allowing for the 90-day total investment horizon Alcoa Corp is expected to generate 0.91 times more return on investment than Spero Therapeutics. However, Alcoa Corp is 1.1 times less risky than Spero Therapeutics. It trades about 0.17 of its potential returns per unit of risk. Spero Therapeutics is currently generating about -0.14 per unit of risk. If you would invest 4,131 in Alcoa Corp on August 27, 2024 and sell it today you would earn a total of 416.00 from holding Alcoa Corp or generate 10.07% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Alcoa Corp vs. Spero Therapeutics
Performance |
| Timeline |
| Alcoa Corp |
| Spero Therapeutics |
Alcoa Corp and Spero Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Alcoa Corp and Spero Therapeutics
The main advantage of trading using opposite Alcoa Corp and Spero Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Alcoa Corp position performs unexpectedly, Spero Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Spero Therapeutics will offset losses from the drop in Spero Therapeutics' long position.The idea behind Alcoa Corp and Spero Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| Spero Therapeutics vs. Assembly Biosciences | Spero Therapeutics vs. Achilles Therapeutics PLC | Spero Therapeutics vs. Instil Bio | Spero Therapeutics vs. CytomX Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Other Complementary Tools
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |